Iksuda Therapeutics develops next-generation antibody-drug conjugate (ADC) therapies to target cancers that are difficult to treat, or resistant to current treatments, without damaging healthy cells.

Motor learning research has developed into two largely separate communities, one focused more on basic and the other more on applied research. Grießbach et al. examine this divide in tasks, theories ...